| Literature DB >> 29188071 |
Julia Dick1, Patrizia Krauß2, Jost Hillenkamp2, Britta Kohlmorgen1, Christoph Schoen1.
Abstract
Introduction.Tropheryma whipplei is the causative agent of Whipple's disease. Gastrointestinal and lymphatic tissues are affected in the majority of cases, resulting in diarrhoea, malabsorption and fever. Here, we report a rare case of ocular manifestation in a patient lacking the typical Whipple symptoms. Case presentation. A 74-year-old Caucasian female presented with blurred vision in the right eye over a period of 1-2 months, accompanied by stinging pain and conjunctival hyperaemia for the last 2 days. Upon admission, visual acuity was hand motion in the affected eye. Ophthalmological examination showed typical signs of intraocular inflammation. Diagnostic and therapeutic pars plana vitrectomy including vitreous biopsy and intravitreal instillation of vancomycin and amikacin was performed within hours of initial presentation. Both microscopic analysis and microbial cultures of the vitreous biopsy remained negative for bacteria and fungi. The postoperative antibiotic regime included intravenous administration of ceftriaxone in combination with topical tobramycin and ofloxacin. Due to the empirical therapy the inflammation ceased and the patient was discharged after 5 days with cefpodoxime orally and local antibiotic and steroidal therapy. Meanwhile, the vitreous body had undergone testing by PCR for the eubacterial 16S rRNA gene, which was found to be positive. Analysis of the PCR product revealed a specific sequence of T. whipplei. Conclusion. In our patient, endophthalmitis was the first and only symptom of Morbus Whipple, while most patients with Whipple's disease suffer from severe gastrointestinal symptoms. 16S rDNA PCR should be considered for any intraocular infection when microscopy and standard culture methods remain negative.Entities:
Keywords: Tropheryma whipplei; Whipple's disease; endophthalmitis; intravenous ceftriaxone; intravitreal vancomycin and amikacin; ocular infection; oral cefpodoxime; oral doxycycline; topic ofloxacin; vitrectomy
Year: 2017 PMID: 29188071 PMCID: PMC5692240 DOI: 10.1099/jmmcr.0.005124
Source DB: PubMed Journal: JMM Case Rep ISSN: 2053-3721
Fig. 1.Products of (a) 16S rRNA PCR and (b) T. whipple i-specific PCR, documented with the QIAxcel ScreenGel system (Qiagen). The size of the amplicon from the eubacterial 16S rRNA PCR is about 800 bp, which is somewhat species-dependent. In the T. whipplei-specific PCR, the anticipated size is 284 bp. M: marker with band sizes as indicated, N: negative control, P: positive control, S: patient sample.
Bacteria identified from vitreous or aqueous humour samples of patients with diagnosed endophthalmitis over a 3-year period (2014–2016)
|
|
|
|
|
|
|---|---|---|---|---|
| Positive | 27 | 23 | 22 | 18 |
| | 11 | 9 | 11 | 9 |
| | 2 | 2 | 2 | 2 |
| Oral streptococci | 5 | 5 | 4 | 4 |
| | 2 | 2 | 2 | 2 |
| | 1 | 1 | 1 | 1 |
| | 1 | 0 | 1 | 0 |
| | 1 | 1 | 0 | 0 |
| | 1 | 1 | 0 | 0 |
| Other | 2 | 1 | 1 | 0 |
| Not distinguishable (PCR≥2 species) | 1 | 1 | 0 | 0 |
| Negative | 19 | 23 | 24 | 28 |